InvestorsHub Logo
Followers 2
Posts 34
Boards Moderated 0
Alias Born 06/06/2017

Re: None

Tuesday, 06/13/2017 11:51:50 AM

Tuesday, June 13, 2017 11:51:50 AM

Post# of 470670
Recent interview with the CEO has some good intell:
https://www.twst.com/interview/interview-with-the-president-and-ceo-anavex-life-sciences-corp-nasdaqavxl
TWST: What drug candidates are the farthest along in the pipeline? Where are they, and when could they potentially be commercialized?

Dr. Missling: The most of advanced compound in our pipeline is ANAVEX 2-73, which is now in a Phase IIa clinical trial in 32 mild-to-moderate Alzheimer’s patients. The next most advanced compounds are ANAVEX 3-71 and ANAVEX 1-41, which are both at the pre-IND stage. The next stage of clinical trials is in preparation for ANAVEX 2-73: a larger Phase II/III study as well as another Phase II in an orphan indication, and it could be Rett syndrome.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News